(Q54135243)

25 May 2018

title

In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens. (English)

1 reference

25 May 2018

author name string

Souli M

series ordinal

1

1 reference

25 May 2018

Wennersten CB

series ordinal

2

1 reference

25 May 2018

Eliopoulos GM

series ordinal

3

1 reference

25 May 2018

publication date

1 April 1998

1 reference

25 May 2018

International Journal of Antimicrobial Agents

published in

1 reference

25 May 2018

volume

10

1 reference

25 May 2018

issue

1

1 reference

25 May 2018

page(s)

23-30

1 reference

25 May 2018

Community-acquired pneumonia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Activity of Quinolones against Gram-Positive Cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Penicillin-resistant Streptococcus pneumoniae in Germany: genetic relationship to clones from other European countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Erythromycin-resistant Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Resistance to Erythromycin in Group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Trends in bacterial resistance to fluoroquinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Quinolone antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

In vitro activity of BAY 12-8039, a novel 8-methoxyquinolone, compared to activities of six fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2898%2900020-X

7 January 2021

10.1016/S0924-8579(98)00020-X

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018